Allen S. Melemed - Jan 7, 2025 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Jan 7, 2025
Transactions value $
$0
Form type
4
Date filed
1/10/2025, 03:00 PM
Previous filing
Feb 2, 2024
Next filing
Feb 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +45.9K +41.74% $0.00 156K Jan 7, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +275K $0.00 275K Jan 7, 2025 Common Stock 275K $3.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 11,481 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 11,481 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 11,481 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 11,482 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 Includes: i) 16,465 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on March 8, 2024; and ii) 7,120 shares acquired under the Issuer's ESPP on September 10, 2024.
F3 One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter.